In vitro inhibition effect of some coumarin compounds on purified human serum paraoxonase 1 (PON1)
dc.authorid | ALICI, Bulent/0000-0001-5009-3223 | |
dc.authorid | Gençer, Nahit/0000-0001-7092-8857 | |
dc.authorid | Gençer, Nahit/0000-0001-7092-8857 | |
dc.authorid | Karataş, Mert Olgun/0000-0001-8500-2088 | |
dc.authorid | Gokce, Basak/0000-0001-8548-9703 | |
dc.authorwosid | ALICI, Bulent/AAG-4203-2019 | |
dc.authorwosid | Gençer, Nahit/HHD-1544-2022 | |
dc.authorwosid | Gençer, Nahit/AAG-4507-2019 | |
dc.authorwosid | Karataş, Mert Olgun/ABG-7848-2020 | |
dc.contributor.author | Gokce, Basak | |
dc.contributor.author | Gencer, Nahit | |
dc.contributor.author | Arslan, Oktay | |
dc.contributor.author | Karatas, Mert Olgun | |
dc.contributor.author | Alici, Bulent | |
dc.date.accessioned | 2024-08-04T20:41:42Z | |
dc.date.available | 2024-08-04T20:41:42Z | |
dc.date.issued | 2016 | |
dc.department | İnönü Üniversitesi | en_US |
dc.description.abstract | Human serum paraoxonase 1 (PON1; EC 3.1.8.1) is a high-density lipoprotein associated, calcium-dependent enzyme that hydrolyses aromatic esters, organophosphates and lactones and can protect the low-density lipoprotein against oxidation. In this study, in vitro effect of some hydroxy and dihydroxy ionic coumarin derivatives (1-20) on purified PON1 activity was investigated. Among these compounds, derivatives 11-20 are water soluble. In investigated compounds, compounds 6 and 13 were found the most active (IC50 = 35 and 34 mu M) for PON1, respectively. The present study has demonstrated that PON1 activity is very highly sensitive to studied coumarin derivatives. | en_US |
dc.description.sponsorship | Balikesir University Research project [2014/54] | en_US |
dc.description.sponsorship | This work has been supported by Balikesir University Research project (2014/54). | en_US |
dc.identifier.doi | 10.3109/14756366.2015.1043297 | |
dc.identifier.endpage | 537 | en_US |
dc.identifier.issn | 1475-6366 | |
dc.identifier.issn | 1475-6374 | |
dc.identifier.issue | 4 | en_US |
dc.identifier.pmid | 25982292 | en_US |
dc.identifier.scopus | 2-s2.0-84964618024 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.startpage | 534 | en_US |
dc.identifier.uri | https://doi.org/10.3109/14756366.2015.1043297 | |
dc.identifier.uri | https://hdl.handle.net/11616/97295 | |
dc.identifier.volume | 31 | en_US |
dc.identifier.wos | WOS:000379783200003 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.ispartof | Journal of Enzyme Inhibition and Medicinal Chemistry | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/openAccess | en_US |
dc.subject | Coumarin derivatives | en_US |
dc.subject | in vitro inhibition | en_US |
dc.subject | paraoxonase | en_US |
dc.title | In vitro inhibition effect of some coumarin compounds on purified human serum paraoxonase 1 (PON1) | en_US |
dc.type | Article | en_US |